SCHEMBL21452910

SCHEMBL21452910

FC1CCCN(c2cc(-c3ccc(C(F)(F)F)cc3)ncn2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ITGB2 P05107 6/20 0.43
▸ ICAM1 P05362 6/20 0.43
▸ ITGAL P20701 6/20 0.43
▸ RPS6KB1 P23443 1/20 0.43
▸ AKT1 P31749 1/20 0.43
▸ DPP4 P27487 3/20 0.41
▸ PRCP P42785 2/20 0.41
▸ LRRK2 Q5S007 4/20 0.40
▸ HRH4 Q9H3N8 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452864 0.83 KMO (0.47) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21452908 0.83 ITGB2 (0.48) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21452909 0.83 ITGB2 (0.48) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21453053 0.79 FAAH (0.43) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21452770 0.79 FAAH (0.43) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21452771 0.79 KMO (0.50) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21452773 0.79 KMO (0.50) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21452764 0.76 RPS6KB1 (0.45) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL21433929 0.74 KDM4E (0.62) NPC1TSHRRECQLRAB9ASMN1; SMN2
SCHEMBL4717327 0.71 ABL1 (0.57) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback